Related Experiment Video
Updated: Jul 17, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Clinical and genetic analysis of essential hypertension with CYB gene m.15024G>A mutation
Insights
A mitochondrial CYB mutation may contribute to essential hypertension by disrupting mitochondrial structure and function. This genetic factor appears to play a synergistic role in disease development.
Area of Science:
- Genetics
- Mitochondrial Biology
- Cardiovascular Disease
Background:
- Essential hypertension is a complex cardiovascular disease with multifactorial causes.
- Mitochondrial dysfunction has been implicated in various pathological conditions, including cardiovascular diseases.
Purpose of the Study:
- To investigate the role of a specific mitochondrial CYB gene mutation (15024G>A) in the pathogenesis of essential hypertension.
Main Methods:
- Analysis of clinical and genetic data from a hypertensive family with the CYB 15024G>A mutation.
- Assessment of mitochondrial function in patient-derived lymphoblastoid cell lines, measuring ATP levels, mitochondrial membrane potential, and reactive oxygen species (ROS).
Main Results:
- The CYB 15024G>A mutation was identified in maternal lineage members of the hypertensive family.
- Cells with the mutation exhibited reduced mitochondrial CYB, ATP, and membrane potential, alongside increased ROS levels.
- The mutation potentially alters mitochondrial CYB protein structure and stability, affecting electron transport function.
Conclusions:
- The mitochondrial CYB 15024G>A mutation may impair mitochondrial structure and function, leading to cellular dysfunction.
- This mutation is suggested to play a synergistic role in the development of essential hypertension.
Objectives:
To explore the role of mitochondrial CYB 15024G>A mutation in the development of essential hypertension.
Methods:
Mitochondrial genome sequences of hypertensive patients were obtained from previous studies. Clinical and genetic data of a hypertensive patient with mitochondrial CYB 15024G>A mutation and its pedigree were analyzed. Lymphocytes derived from patient and family members were transformed into immortalized lymphoblastoid cell lines, and the levels of adenosine triphosphate (ATP), mitochondrial membrane potential and intracellular reactive oxygen species (ROS) were detected.
Results:
The penetrance of this essential hypertension family was 42.9%, and the age of onset was 46-68 years old. Mitochondrial genome sequencing results showed that all maternal members carried a highly conserved mitochondrial CYB 15024G>A mutation. This mutation could affect the free energy of mitochondrial CYB for secondary and tertiary structure and protein folding, thereby changing its structural stability and the structure of the electron transfer function area around the mutation site. Compared with the control, the cell line carrying the mitochondrial CYB 15024G>A mutation showed significantly decreased levels of mitochondrial CYB, ATP and mitochondrial membrane potential, and increased levels of ROS (P<0.01).
Conclusions:
Mitochondrial CYB 15024G>A mutation may affect the structure of respiratory chain subunits and mitochondrial function, leading to cell dysfunction, which suggests that the mutation may play a synergistic role in essential hypertension.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Hypertension II: Pathophysiology
Genetic Lingo
Incomplete Dominance